NHS' role in growing local economies
•Download as PPTX, PDF•
1 like•133 views
The document summarizes the role and activities of Academic Health Science Networks (AHSNs) in the UK. It discusses how AHSNs act as catalysts and connectors to spread healthcare innovations, improve health outcomes, and generate economic growth. It provides examples of innovations that have benefited from AHSN support and been adopted in the NHS. It also outlines goals and initiatives around building partnerships across health and social care systems and supporting life sciences industry and innovation infrastructure.
Recommended
More Related Content
What's hot
What's hot (20)
Similar to NHS' role in growing local economies
Similar to NHS' role in growing local economies (20)
More from Innovation Agency
More from Innovation Agency (20)
Recently uploaded
Recently uploaded (20)
NHS' role in growing local economies
- 1. Presentation 1 The NHS’ role in growing local economies Dr Liz Mear Chief Executive @MearLiz
- 2. Presentation 1 15 Academic Health Science Networks – innovation, health, economic growth, advancing technology
- 3. Presentation 1 NHS England’s four objectives for the AHSNs Focusing on the needs of patients and local populations Building a culture of partnership and collaboration Speeding up adoption of innovation into practice to improve clinical outcomes and patient experience Creating wealth Plus the three gaps identified in the NHS Five Year Forward View (health and wellbeing, care and quality, funding and efficiency)
- 4. We are catalysts, connectors and collaborators • AHSNs are catalysts for the spread of innovation at pace and scale - improving health, generating economic growth and helping facilitate change across whole health and social care economies • AHSNs connect - as member organisations we are well placed to mobilise cross-sector buy-in, developing powerful regional networks of NHS and academic organisations, local authorities, third sector and industry: responding to diverse patient and population needs through partnership and collaboration • AHSNs create the right environment for relevant industries to work with the health and social care system
- 5. Our role in generating economic growth in life sciences and health care • Spreading innovation • Improving health • Generating economic growth • Advancing health technology
- 6. 6 The Innovation PathwayThe Innovation Pathway AHSNs help companies & innovators navigate a fragmented landscape
- 7. Key AHSN impacts since 2013 • 6.3M people have benefited from AHSN activity • 226 innovations have been adopted via significant AHSN involvement • Over £330M in innovation funding has been leveraged by AHSNs • AHSN-enabled innovations have been implemented in over 11,400 sites • Over 500 jobs have been created
- 8. ITT was introduced to incentivise the adoption and spread of transformational innovation in the NHS. It aims to remove the need for multiple local price negotiations and guarantee automatic reimbursement when an approved innovation is used. At the same time the ITT allows NHS England to optimise its purchasing power and negotiate national “bulk buy” price discounts where applicable on behalf of the NHS. 2017-18 is the first year of the ITT and a pathfinder year; 6 themes have been identified which could provide innovation benefits to the NHS at scale. Guidance available here:- https://www.england.nhs.uk/resources/pay-syst/development/tech-tariff-17-19- technical-notes Accessing the zero cost NHS Innovation and Technology Tariff 2017-18
- 9. • Non-Injectable Arterial Connector (NIC): prevents wrong route drug administration (produced in Liverpool) • Pneux: stops ventilator associated pneumonia, the leading cause of hospital acquired mortality in ITUs Innovation examples – ITT products
- 10. Presentation 1 25 Innovation Fellows: innovative health technologies and services into action National Innovation Accelerator Francis White spreading the use of Kardia from AliveCor, the UK’s first mobile heart monitor Dr Lloyd Humphries Patient Knows Best Dr Penny Newman Health Coaching
- 11. Other products • Through our network of AHSNs: STarT Back from West Midlands, Chat Health from Eastern AHSN • Atrial fibrillation: eleven AHSNs sharing new ways of preventing stroke through testing and prescribing; commissioning toolkit • Mental health: House of Memories in Liverpool now being adopted by three other AHSNs • Importing innovation expertise
- 14. Our five goals
- 15. Presentation 1 Whole Health and Care Economy working • Establishing a core shared purpose • Establishing strong interpersonal relationships • Agreement on why we are doing this – what are the service user benefits from the transformation? • Shared mechanisms for managing financial risk and benefit • Shared understanding of when the system needs to work together and when it needs to compete
- 16. Presentation 1 AHSN work is guided by our members – our Board: • Provider trusts • Commissioners – CCGs and NHS England • Strategic Clinical Network • Local Enterprise Partnerships (LEPs) • Public Health England • Health Education England • Universities • Clinical Research Network • ABPI and ABHI • Healthwatch • Research and innovation hubs • North West Coast Collaboration for Applied • Health Research (CLAHRC) • Two STPs
- 17. Presentation 1 Regional Transformation Partnerships x 2 • Addressing the three gaps – health and wellbeing, care and quality, finance • Unlocking local energy and leadership • Resource for the future to drive coherence between silos • All system partners fully involved • Financial balance across a wide region • Focus on prevention
- 18. Presentation 1 Supporting infrastructure for economic growth Total amount Innovation Agency investment in the region: £100m to date for a £1m investment, leveraging additional external funding examples; • Health Innovation Campus, University of Lancaster, due to open in 2019 • Liverpool Bio-Innovation Hub at University of Liverpool - opened February 2016 • Alder Hey Research and Education Centre - opened October 2015 • Alder Hey Innovation Hub for digital and sensor technologies - opened March 2016 • Centre for Integrated Health Science, Chester, Countess of Chester NHS Foundation Trust and Cheshire and Wirral Partnership NHS Foundation Trust - opened April 2015 • Accelerator Hub, Royal Liverpool & Broadgreen University Hospitals NHS Trust – opening autumn 2017 • Chorley Digital Park – due to open in 2018
- 19. Presentation 1 Supporting infrastructure for economic growth Alder Hey Children’s Hospital Pump-prime funding into Institute in the Park and Living Hospital Lab - helping to leverage £12m ERDF funding
- 20. Presentation 1 Investment to support our region • ERDF – 3 programmes (£6 million) • Active member of ECHAlliance, a network of connected health ecosystems in over 30 countries • STOPandGO – a €17m project to procure 7 new services through PPI processes in 4 different countries – local investment in digital prevention technologies - - £600k to Liverpool County Council • ENSAFE - €2m project to support prevention and self care for older people in 4 different countries • ALTAS - A € 360k project to design an e-learning package for Assisted Living Technologies across Europe • EIT KIC Health – € 2.1 billion for 140 organisations to develop products and services for health
- 21. Lancashire Lead Partner with Lancaster University as delivery partner Liverpool Delivery Partner with Liverpool CCG lead partner Cheshire & Warrington Lead Partner with GM AHSN as delivery partner Which areas do the programmes cover?
- 22. • Accessing funding • Evaluation and evidence • Procurement • Regulatory approval • Commercial tools • Positioning, presenting, pitching What do the programmes offer?
- 23. Presentation 1 The £6m over the next three years will help: • Support 280 healthcare small and medium size enterprises (SMEs) • 150 SMEs recruit additional staff due to expansion • 75 SMEs develop new products for the NHS • 50 New SMEs will be created Employment decreases health inequalities and improves health Outcomes of Investment
- 27. • Champions of change, learning from innovation leaders • Creating a culture of innovation; part of the AHSN • Network for co-creating new technologies and systems Innovation Scouts
- 28. Dr Liz Mear Chief Executive Liz.Mear@innovationagencynwc.nhs.uk T: 01772 520260 M: 07891 698692 Lorna Green Commercial Director lorna.green@innovationagencynwc.nhs.uk T: 01772 520259 M: 07507 845982 Contact us
Editor's Notes
- This is hard work!! Investment of £1 billion to £2 billion for innovation , investment in NIHR who are changing how they work. CRN, CLAHRCs, Senate links
- This is hard work!! Investment of £1 billion to £2 billion for innovation , investment in NIHR who are changing how they work. CRN, CLAHRCs, Senate links
- 2 ITT innovations which improve safety in intensive care units: The PneuX is designed to stop ventilator associated pneumonia (VAP), the leading cause of Hospital acquired mortality in Intensive Care Units affecting up to 20,000 patients each year, with a 30% mortality rate costing the NHS £10k - £20k per episode. PneuX is a cuffed ventilation tube and an electronic cuff monitoring and inflation device which prevents leakage of bacterial laden oral and stomach contents to the lung - a problem associated with all standard tubes. The Non Injectable Arterial Connector (NIC) enables conventional arterial line sampling for all patients in operating theatres and intensive care and it also improves safety by preventing wrong route drug administration. If medication is accidentally given to a patient via the wrong route, there is risk of damage to a patient’s blood vessel and surrounding tissue and in extreme circumstances surgical amputation.
- We support the National Innovation Accelerator along with UCLPartners. 17 Fellows with innovative technologies or practices. In its first year, the 17 fellows who joined the programme received support to take their high impact innovations to more than 345 NHS providers and commissioners, raised over £17m in funding and won 12 awards. An additional process to procure mobile ECG devices for community use, funded by NHSE, is being led by the Innovation Agency and adoption will be across all 15 AHSNs (375 devices for the NWC region) We support 3 Fellows – Francis White, Penny Newman and Lloyd Humphries. Each year, the NIA looks for the best national and international evidence-based healthcare innovators. Another 8 Fellows are currently being recruited – the results of the applications will be announced in November 2016.
- response from the local health economy to this challenge, talking about how Innovation Agency has seen these changes at a strategic level and the importance of health and wealth locally, in terms of bringing in investment which can support public services. References to making it easier for industry to work with NHS, bringing in funding, alignment with Combined Authority (and new Mayor) – and general importance of relationships
- response from the local health economy to this challenge, talking about how Innovation Agency has seen these changes at a strategic level and the importance of health and wealth locally, in terms of bringing in investment which can support public services. References to making it easier for industry to work with NHS, bringing in funding, alignment with Combined Authority (and new Mayor) – and general importance of relationships
- Leaders need to engage and address the behavioural aspects of the system and not just offer rational, analytical diagnoses and plans New authority and devolution workshop
- Overview of current bids and funding opportunities This report summarises the current bids in progress that the Innovation Agency is applying for with partners or supporting. European Structural and Investment Funds (ESIF) The European Structural and Investment Funds (ESIF) are the EU’s main funding programmes for supporting growth and jobs across the EU. In the UK, the ESIF are made up of the: European Regional Development Fund (ERDF) European Social Fund (ESF) European Agricultural Fund for Rural Development (EAFRD) European Maritime and Fisheries Fund (EMFF) In England the Managing Authorities are: Department for Communities and Local Government (DCLG) for ERDF Department for Work and Pensions (DWP) for ESF Department for Environment, Food and Rural Affairs for EAFRD We are partners on four ERDF bids as follows: Bid Summary Partners ERDF value for Innovation Agency ERDF Value total project Stage Anticipated start date Health Enterprise Hub Liverpool City Region: This is a bid to support the development of a more integrated innovation ecosystem within LCR building on the work LCCG have done through the Mi programme and beyond and the innovation agenda at Alder Hey. Di3: business support to students / start-ups for digital health technologies working with them to identify and understand unmet needs in the NHS and of citizens to inform product design and development and then to support them to commercialise. Led by LCCG, including Alder Hey and LJMU, LCR LEP and AIMES Led by Lancaster University with Innovation Agency as the only partner £260K ERDF over 3 years (£260K match required) £525k over 3 years (£350k match required) £1.5m £5.8m Second (final) stage application submitted in March. Decision awaited. Second stage application due 16 May 2016 July 2016 July 2016 Business Assist Lancs: Building capacity and capability in health and life science businesses in Lancashire Led by the Innovation Agency with Lancs Uni as partner £484k over 3 years (£320k match) £916k Second stage application due 16 May 2016 July 2016 Business Assist Cheshire & Warrington Led by the Innovation Agency in partnership with GM AHSN tbc but circa £400k over 3 years (50% match required) Tbc but circa £750k Outline application due 27 May 2016 September / October 2016 We were a partner on the LCR New Markets 2 programme to provide intensive business support to SME s within LCR wanting to engage with and sell to the NHS and health and social care markets. This is led by the combined authority, including a consortia of 14 partners providing all types of business support (incl. Universities, Mersey Maritime, STFC). £185k over 3 years (£185k match required) and has been approved but is still awaiting the grant letter. The candidate identified to deliver the project has subsequently taken another position due to the delays and given the size of the project, the difficulties encountered thus far and the joint and several liability for claw back we have taken the decision to withdraw from this project and focus on those listed above which carry much less financial risk and are with existing partners and collaborators of the Innovation Agency.
- Overview of current bids and funding opportunities This report summarises the current bids in progress that the Innovation Agency is applying for with partners or supporting. European Structural and Investment Funds (ESIF) The European Structural and Investment Funds (ESIF) are the EU’s main funding programmes for supporting growth and jobs across the EU. In the UK, the ESIF are made up of the: European Regional Development Fund (ERDF) European Social Fund (ESF) European Agricultural Fund for Rural Development (EAFRD) European Maritime and Fisheries Fund (EMFF) In England the Managing Authorities are: Department for Communities and Local Government (DCLG) for ERDF Department for Work and Pensions (DWP) for ESF Department for Environment, Food and Rural Affairs for EAFRD We are partners on four ERDF bids as follows: Bid Summary Partners ERDF value for Innovation Agency ERDF Value total project Stage Anticipated start date Health Enterprise Hub Liverpool City Region: This is a bid to support the development of a more integrated innovation ecosystem within LCR building on the work LCCG have done through the Mi programme and beyond and the innovation agenda at Alder Hey. Di3: business support to students / start-ups for digital health technologies working with them to identify and understand unmet needs in the NHS and of citizens to inform product design and development and then to support them to commercialise. Led by LCCG, including Alder Hey and LJMU, LCR LEP and AIMES Led by Lancaster University with Innovation Agency as the only partner £260K ERDF over 3 years (£260K match required) £525k over 3 years (£350k match required) £1.5m £5.8m Second (final) stage application submitted in March. Decision awaited. Second stage application due 16 May 2016 July 2016 July 2016 Business Assist Lancs: Building capacity and capability in health and life science businesses in Lancashire Led by the Innovation Agency with Lancs Uni as partner £484k over 3 years (£320k match) £916k Second stage application due 16 May 2016 July 2016 Business Assist Cheshire & Warrington Led by the Innovation Agency in partnership with GM AHSN tbc but circa £400k over 3 years (50% match required) Tbc but circa £750k Outline application due 27 May 2016 September / October 2016 We were a partner on the LCR New Markets 2 programme to provide intensive business support to SME s within LCR wanting to engage with and sell to the NHS and health and social care markets. This is led by the combined authority, including a consortia of 14 partners providing all types of business support (incl. Universities, Mersey Maritime, STFC). £185k over 3 years (£185k match required) and has been approved but is still awaiting the grant letter. The candidate identified to deliver the project has subsequently taken another position due to the delays and given the size of the project, the difficulties encountered thus far and the joint and several liability for claw back we have taken the decision to withdraw from this project and focus on those listed above which carry much less financial risk and are with existing partners and collaborators of the Innovation Agency.
- Through the Scouts network, 3D Lifeprints was introduced to Liverpool Heart and Chest Hospital who are now going to commission 3D printing of organs. This came about after the Scouts were taken on a tour of Alder Hey’s Institute in the Park, and Liverpool Heart and Chest scout Mark Jackson was impressed by the impact of 3D printing. Surgeons at Alder Hey have used 3D prints to plan surgery – reducing the time spent in theatre, which saves time and money; improving outcomes for patients; used to help inform patients and families and explain what will happen.